For best results when printing this announcement, please click on link below:
https://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20250409:nRSI3678Ea&default-theme=true
RNS Number : 3678E Dr. Martens PLC 09 April 2025
Dr. Martens plc (the 'Company')
Director/PDMR Shareholding
Notification of Transactions by Directors/Persons Discharging Managerial
Responsibility
The Company announces that it was notified on 9 April 2025 of the following
transactions in the Company's Ordinary 1p shares undertaken by directors /
persons discharging managerial responsibility ('PDMRs') under the Company's
Share Incentive Plan ('SIP').
The SIP is an HMRC approved, all-employee scheme under which participating
employees are able to purchase shares in the Company from monthly salary
('Partnership Shares') and receive allocations of free 'Matching Shares',
awarded at a rate of one Matching Share for every one Partnership Share
purchased by a participating employee, from the Company.
The relevant notifications set out below are provided in accordance with the
requirements of Article 19 of the UK Market Abuse Regulation.
1 Details of the person discharging managerial responsibilities/person closely
associated
a) Name Ije Nwokorie
2 Reason for the notification
a) Position/status PDMR (Chief Executive Officer)
b) Initial notification/Amendment Initial notification
3 Details of the issuer, emission allowance market participant, auction
platform, auctioneer or auction monitor
a) Name Dr. Martens plc
b) LEI 213800QPT8YM6NQZPH28
4 Details of the transaction(s): section to be repeated for (i) each type of
instrument; (ii) each type of transaction; (iii) each date; and (iv) each
place where transactions have been conducted
a) Description of the financial instrument, type of instrument Ordinary shares of GBP 0.01
Identification code ISIN: GB00BL6NGV24
b) Nature of the transaction Acquisition of dividend shares under the SIP.
c) Price(s) and volume(s) Price(s) Volume(s)
£0.4692 79
d) Aggregated information
n/a (single transaction)
- Aggregated volume n/a (single transaction)
- Price
e) Date of the transaction 8 April 2025
f) Place of the transaction London Stock Exchange (XLON)
d)
Aggregated information
- Aggregated volume
- Price
n/a (single transaction)
n/a (single transaction)
e)
Date of the transaction
8 April 2025
f)
Place of the transaction
London Stock Exchange (XLON)
1 Details of the person discharging managerial responsibilities/person closely
associated
a) Name Giles Wilson
2 Reason for the notification
a) Position/status PDMR (Chief Financial Officer)
b) Initial notification/Amendment Initial notification
3 Details of the issuer, emission allowance market participant, auction
platform, auctioneer or auction monitor
a) Name Dr. Martens plc
b) LEI 213800QPT8YM6NQZPH28
4 Details of the transaction(s): section to be repeated for (i) each type of
instrument; (ii) each type of transaction; (iii) each date; and (iv) each
place where transactions have been conducted
a) Description of the financial instrument, type of instrument Ordinary shares of GBP 0.01
Identification code
ISIN: GB00BL6NGV24
b) Nature of the transaction Acquisition of dividend shares under the SIP.
c) Price(s) and volume(s) Price(s) Volume(s)
£0.4692 58
d) Aggregated information
n/a (single transaction)
- Aggregated volume n/a (single transaction)
- Price
e) Date of the transaction 8 April 2025
f) Place of the transaction London Stock Exchange (XLON)
d)
Aggregated information
- Aggregated volume
- Price
n/a (single transaction)
n/a (single transaction)
e)
Date of the transaction
8 April 2025
f)
Place of the transaction
London Stock Exchange (XLON)
For further information please contact:
Zhwan Woof
Secretariat Assistant
+44(0)7584254518
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
or visit
www.rns.com (http://www.rns.com/)
.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
. END DSHUKVORVKUSRAR